Sanofi Logo

Sanofi

Global biopharma firm researching, developing & marketing prescription medicines & vaccines.

SAN | PA

Overview

Corporate Details

ISIN(s):
FR0000120578 (+39 more)
LEI:
549300E9PC51EN656011
Country:
France
Address:
46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sanofi is a global biopharmaceutical company engaged in the research, development, manufacturing, and marketing of therapeutic solutions, primarily prescription medicines and vaccines. The company leverages science and digital technologies, including AI, to discover and deliver treatments across various healthcare areas. With a worldwide presence, Sanofi operates through multiple divisions and specialized R&D-focused subsidiaries like Ablynx, Kymab, and Principia to advance its pipeline. It aims to transform the practice of medicine and improve public health by providing innovative healthcare products to millions of people globally. The company also manufactures and supplies active pharmaceutical ingredients through its Sanofi Active Ingredient Solutions arm.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-01 18:30
Sanofi: Disclosure of trading in own shares
English 11.1 MB
2025-12-01 18:30
Sanofi : Déclaration des transactions sur actions propres
English 11.1 MB
2025-11-24 18:30
Sanofi : Déclaration des transactions sur actions propres
English 12.4 MB
2025-11-24 18:30
Sanofi: Disclosure of trading in own shares
English 12.4 MB
2025-11-13 18:30
Sanofi: Information concerning the total number of voting rights and shares – O…
English 141.5 KB
2025-11-13 18:30
Sanofi: Informations relatives au nombre de droits de vote et d'actions – Octob…
French 117.1 KB
2025-11-03 18:30
Sanofi : Déclaration des transactions sur actions propres
French 10.8 MB
2025-11-03 18:30
Sanofi: Disclosure of trading in own shares
English 10.8 MB
2025-10-31 18:30
Sanofi : Déclaration des transactions sur actions propres - Revised
French 9.1 MB
2025-10-31 18:30
Sanofi: Disclosure of trading in own shares - Revised
English 9.1 MB
2025-10-27 18:30
Sanofi : Déclaration des transactions sur actions propres
French 9.1 MB
2025-10-24 07:30
Communiqué de presse : T3 : croissance continue du chiffre d’affaires et du bén…
French 574.1 KB
2025-10-24 07:30
Press release: Q3: continued sales and earnings progress
English 376.4 KB
2025-10-20 18:30
Sanofi: Disclosure of trading in own shares
English 9.3 MB
2025-10-20 18:30
Sanofi : Déclaration des transactions sur actions propres
French 9.3 MB

Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sanofi

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sanofi via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-05-02 N/A Other Buy 71,423 N/A
2024-04-26 N/A Other Buy 1,000 91,380.00 EUR
2023-06-09 N/A Other Buy 9 856.04 EUR
2023-05-02 N/A Other Buy 65,205 6,364,008.00 EUR
2023-05-02 N/A Other Buy 500 48,835.00 EUR

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Develops medical devices, diagnostics, nutritionals, and pharmaceuticals for global health.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900

Talk to a Data Expert

Have a question? We'll get back to you promptly.